Dosidal · Switzerland

Bendamustin Sandoz, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:67412 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 67412
atc: L01AA09
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2019-07-11
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: L01AA09
authorisation_number: 67412
form: PULPI
holder: Sandoz Pharmaceuticals AG
holder_partner_nr: 1006431
it_number: 07.16.1.
name: Bendamustin Sandoz, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
mlUSirfEVw-v1p0iDQaMDQfgBW3-CkgZ6KUdDUp5N4vAPPOP2Q4OFJ0M0fuSLvVpRh6So9wGYmQ3_Qkjj0Ey7g
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:67412 · Related records in other markets · Dosidal